UPDATE 1-EU regulator backs continued use of Ariad Pharma's leukaemia drug
October 24, 2014 at 08:41 AM EDT
Oct 24 (Reuters) - European regulators recommended continued use of Ariad Pharmaceuticals Inc's cancer drug, Iclusig, in its already approved indications to treat certain kinds of leukaemia.